Startup Aims to Find Cancer with miRNAs | GenomeWeb

By assessing the microRNAs floating in a person's blood, startup Miroculus aims to aid in the early diagnosis of cancer, Wired reports.

Fay Christodoulou and her colleagues formed Miroculus after meeting at the Silicon Valley incubator Singularity University to make a low-cost, open-source diagnostic they called Miriam. Their goal is for untrained workers in clinics around the world to be able to use Miriam to screen for cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.